Theratechnologies Files 6-K Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Sep 17, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, regulatory-update
TL;DR
Theratechnologies filed a 6-K on Sept 17, 2025, with a press release from Sept 16. Canadian company.
AI Summary
Theratechnologies Inc. filed a Form 6-K on September 17, 2025, reporting information for the month of September 2025. The filing includes a press release dated September 16, 2025, as Exhibit 99.1. The company is incorporated in Canada and its principal executive offices are located in Montreal, Quebec.
Why It Matters
This filing provides an update on Theratechnologies' regulatory reporting and corporate activities, which is important for investors to stay informed about the company's ongoing operations and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial or operational information that would typically increase risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
- September 16, 2025 (date) — Press Release Date
- September 17, 2025 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
What specific exhibit is included in this 6-K filing?
This 6-K filing includes Exhibit 99.1, which is a Press Release dated September 16, 2025.
Where are Theratechnologies Inc.'s principal executive offices located?
Theratechnologies Inc.'s principal executive offices are located at 2015 Peel Street, Suite 1100, Montreal, Quebec, H3A 1T8, Canada.
What is the fiscal year end for Theratechnologies Inc.?
The fiscal year end for Theratechnologies Inc. is November 30 (1130).
Is Theratechnologies Inc. required to file annual reports on Form 20-F or Form 40-F?
The filing indicates that Theratechnologies Inc. files annual reports under cover of Form 20-F.
Filing Stats: 151 words · 1 min read · ~1 pages · Grade level 11.1 · Accepted 2025-09-17 10:10:03
Filing Documents
- d29971d6k.htm (6-K) — 8KB
- d29971dex991.htm (EX-99.1) — 12KB
- g29971g0917180419532.jpg (GRAPHIC) — 3KB
- 0001193125-25-205635.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. THERATECHNOLOGIES INC. By: /s/ Jocelyn Lafond Name: Jocelyn Lafond Title: General Counsel and Corporate Secretary Date: September 17, 2025